Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy

Journal of Periodontology

Volumn 73, Issue 1, 2002, Pages 103-109

  Buduneli, Nurcan ^a   Vardar, Saynur ^a   Atilla, Gül ^a   Sorsa, Timo ^a   Luoto, Hanne ^a   Baylas, Haluk ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Collagenase; Gingival crevicular fluid analysis; Matrix; Meloxicam therapeutic use; Metalloproteinases; Periodontitis drug therapy

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; MELOXICAM; NEUTROPHIL COLLAGENASE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG SELECTIVITY; FEMALE; GINGIVA BLEEDING; GINGIVITIS; HUMAN; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; MALE; MEDICAL ASSESSMENT; PERIODONTICS; PREVENTIVE DENTISTRY; SAMPLE SIZE; SCORING SYSTEM; STATISTICAL ANALYSIS; TOOTH PLAQUE;

ADULT; ALVEOLAR BONE LOSS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; CYCLOOXYGENASE INHIBITORS; DENTAL PLAQUE INDEX; DENTAL SCALING; DOUBLE-BLIND METHOD; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; GINGIVAL CREVICULAR FLUID; HUMANS; ISOENZYMES; MALE; MATCHED-PAIR ANALYSIS; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTITIS; PLACEBOS; ROOT PLANING; STATISTICS, NONPARAMETRIC; THIAZINES; THIAZOLES;

EID: 0036200894     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2002.73.1.103     Document Type: Article

References (49)

1. Matrix metalloproteinases: A review
2. Role of matrix metalloproteinases in human periodontal disease
3. Modulation of matrix metalloproteinase activities in periodontitis as a treatment strategy
4. GCF levels of MMP-3 and MMP-8 following placement of bioresorbable membranes
5. Comparison of interstitial collagenases from human gingiva, sulcular fluid and polymorphonuclear leukocytes
6. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva
7. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: Role of active enzyme in human periodontitis
8. Salivary collagenase, elastase- and trypsin-like proteases as biochemical markers of periodontal tissue destruction in adult and localized juvenile periodontitis
9. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and bone-type collagenase in gingival crevicular fluid during adult periodontitis
10. Three-year trial of flurbiprofen treatment in humans-post treatment period
11. Flurbiprofen treatment of human periodontitis: Effect on alveolar bone height and metabolism
12. Efficacy of meclofenomate sodium (Meclomen) in the treatment of rapidly progressive periodontitis
13. Cycylooxygenase-1 and -2 in rheumatic disease: Implications for non-steroidal anti-inflammatory drug therapy
14. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by RNA splicing
15. Towards a better aspirin
16. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2
17. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats
18. Meloxicam and indomethacin activity on human matrix metalloproteinases in synovial fluid
19. Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoarthritic cartilage
20. Collagenase and collagenase inhibitor activities in crevicular fluid of patients receiving treatment for localized juvenile periodontitis
21. Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients
22. Development of a classification system for periodontal diseases and conditions
23. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition
24. Motivation and instruction
25. Effect of non-surgical periodontal therapy. (IV) Operator variability
26. Evaluation and modification of spectrophotometric procedures for analysis of lactate dehydrogenase, beta-glucuronidase and aryl-sulphatase in human gingival crevicular fluid collected with filter-paper strips
27. Method of collection. Crevicular Fluid Updated
28. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-α and doxycycline
29. In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis
30. Drug therapy of post-operative and post-traumatic edema
31. Collagenase activity and protein content of sulcular fluid after scaling and occlusal adjustment of teeth with deep periodontal pockets
32. Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluids in adult periodontitis
33. Enzyme activity in human gingival crevicular fluid: Considerations in data reporting based on analysis of individual crevicular sites
34. The expression, activation and chemotherapeutic inhibition of matrix metalloproteinase-8 (neutrophil collagenase/collagenase-2) in inflammation
35. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis
36. Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions
37. In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis
38. Early healing events at the dentin-connective tissue interface. Light and transmission electron microscopy observations
39. Effects of treatment on gingival crevicular collagenase, stromelysin and tissue inhibitor of metalloproteinases and their ability to predict response to treatment
40. Measurement of prostaglandin E in gingival crevicular fluid
41. Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients
42. 2, and matrix metalloproteinase-8 in refractory periodontitis sites in smokers and non-smokers
43. Anti-inflammatory drugs and their mechanism of action
44. SC-58635, a highly selective inhibitor of COX-2, is an effective analgesic in an acute post-surgical pain model
45. Tolerability of multiple administration of intramuscular meloxicam: A comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis
46. Chondrocyte matrix metalloproteinase-8: Upregulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints
47. Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase
48. Tetracyclines suppress MMP activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage
49. Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease